(North America, Europe, Asia-Pacific, South America, Middle East and Africa) Benign Prostatic Hyperplasia Devices Market

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Benign Prostatic Hyperplasia Devices Market 2018, Forecast to 2023

May, 2019 | Report ID: 74881 | 136 | Medical Devices
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.

Scope of the Report:
This report focuses on the Benign Prostatic Hyperplasia Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The worldwide market for Benign Prostatic Hyperplasia Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others

Market Segment by Applications, can be divided into
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others


There are 15 Chapters to deeply display the global Benign Prostatic Hyperplasia Devices market.
Chapter 1, to describe Benign Prostatic Hyperplasia Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Benign Prostatic Hyperplasia Devices, with sales, revenue, and price of Benign Prostatic Hyperplasia Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Benign Prostatic Hyperplasia Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Market Overview

1.1 Benign Prostatic Hyperplasia Devices Introduction

1.2 Market Analysis by Type

1.2.1 Transurethral Resection of the Prostate (TURP)

1.2.2 Transurethral Microwave Therapy (TUMT)

1.2.3 Transurethral Needle Ablation of the Prostate (TUNA)

1.2.4 Laser Surgery

1.2.5 Prostatic Stenting

1.2.6 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals and Clinics

1.3.2 Ambulatory Surgical Centers(ASC)

1.3.3 Home

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Lumenis

2.1.1 Business Overview

2.1.1.1 Lumenis Description

2.1.1.2 Lumenis Headquarter, Main Business and Finance Overview

2.1.2 Lumenis Benign Prostatic Hyperplasia Devices Product Introduction

2.1.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.1.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.1 Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.2 Global Lumenis Benign Prostatic Hyperplasia Devices Market Share in 2017

2.2 Olympus corporation

2.2.1 Business Overview

2.2.1.1 Olympus corporation Description

2.2.1.2 Olympus corporation Headquarter, Main Business and Finance Overview

2.2.2 Olympus corporation Benign Prostatic Hyperplasia Devices Product Introduction

2.2.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.2.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.1 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.2 Global Olympus corporation Benign Prostatic Hyperplasia Devices Market Share in 2017

2.3 Urologix

2.3.1 Business Overview

2.3.1.1 Urologix Description

2.3.1.2 Urologix Headquarter, Main Business and Finance Overview

2.3.2 Urologix Benign Prostatic Hyperplasia Devices Product Introduction

2.3.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.3.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.1 Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.2 Global Urologix Benign Prostatic Hyperplasia Devices Market Share in 2017

2.4 Boston Scientific corporation

2.4.1 Business Overview

2.4.1.1 Boston Scientific corporation Description

2.4.1.2 Boston Scientific corporation Headquarter, Main Business and Finance Overview

2.4.2 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Introduction

2.4.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.4.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.1 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.2 Global Boston Scientific corporation Benign Prostatic Hyperplasia Devices Market Share in 2017

2.5 Lisa Laser

2.5.1 Business Overview

2.5.1.1 Lisa Laser Description

2.5.1.2 Lisa Laser Headquarter, Main Business and Finance Overview

2.5.2 Lisa Laser Benign Prostatic Hyperplasia Devices Product Introduction

2.5.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.5.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.1 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.2 Global Lisa Laser Benign Prostatic Hyperplasia Devices Market Share in 2017

2.6 Medifocus

2.6.1 Business Overview

2.6.1.1 Medifocus Description

2.6.1.2 Medifocus Headquarter, Main Business and Finance Overview

2.6.2 Medifocus Benign Prostatic Hyperplasia Devices Product Introduction

2.6.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.6.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.1 Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.2 Global Medifocus Benign Prostatic Hyperplasia Devices Market Share in 2017

2.7 Neotrac

2.7.1 Business Overview

2.7.1.1 Neotrac Description

2.7.1.2 Neotrac Headquarter, Main Business and Finance Overview

2.7.2 Neotrac Benign Prostatic Hyperplasia Devices Product Introduction

2.7.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.7.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.1 Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.2 Global Neotrac Benign Prostatic Hyperplasia Devices Market Share in 2017

2.8 ProArc Medical LTD

2.8.1 Business Overview

2.8.1.1 ProArc Medical LTD Description

2.8.1.2 ProArc Medical LTD Headquarter, Main Business and Finance Overview

2.8.2 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Introduction

2.8.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.8.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.3.1 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.3.2 Global ProArc Medical LTD Benign Prostatic Hyperplasia Devices Market Share in 2017

2.9 Urotech GMBH

2.9.1 Business Overview

2.9.1.1 Urotech GMBH Description

2.9.1.2 Urotech GMBH Headquarter, Main Business and Finance Overview

2.9.2 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Introduction

2.9.2.1 Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

2.9.2.2 Benign Prostatic Hyperplasia Devices Product Information

2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.3.1 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.3.2 Global Urotech GMBH Benign Prostatic Hyperplasia Devices Market Share in 2017

3 Global Benign Prostatic Hyperplasia Devices Market Competition, by Manufacturer

3.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global Benign Prostatic Hyperplasia Devices Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017

3.4.2 Top 5 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017

3.5 Market Competition Trend

4 Global Benign Prostatic Hyperplasia Devices Market Analysis by Regions

4.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Regions

4.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Regions (2013-2018)

4.1.2 Global Benign Prostatic Hyperplasia Devices Revenue by Regions (2013-2018)

4.2 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2013-2018)

4.3 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2013-2018)

4.5 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2013-2018)

5 North America Benign Prostatic Hyperplasia Devices by Countries, Type, Application and Manufacturers

5.1 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries

5.1.1 North America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

5.1.2 North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

5.1.3 United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

5.1.4 Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

5.1.5 Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

5.2 North America Benign Prostatic Hyperplasia Devices Sales and Revenue (Value) by Manufacturers (2016-2017)

5.2.1 North America Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2016-2017)

5.2.2 North America Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2016-2017)

5.3 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

5.3.1 North America Benign Prostatic Hyperplasia Devices Sales and Sales Share by Type (2013-2018)

5.3.2 North America Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Type (2013-2018)

5.4 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Application (2013-2018)

5.4.1 North America Benign Prostatic Hyperplasia Devices Sales and Sales Share by Application (2013-2018)

5.4.2 North America Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Application (2013-2018)

6 Europe Benign Prostatic Hyperplasia Devices by Countries, Type, Application and Manufacturers

6.1 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries

6.1.1 Europe Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

6.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

6.1.3 Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

6.1.4 UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

6.1.5 France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

6.1.6 Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

6.1.7 Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

6.2 Europe Benign Prostatic Hyperplasia Devices Sales and Revenue (Value) by Manufacturers (2016-2017)

6.2.1 Europe Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2016-2017)

6.2.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2016-2017)

6.3 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

6.3.1 Europe Benign Prostatic Hyperplasia Devices Sales and Sales Share by Type (2013-2018)

6.3.2 Europe Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Type (2013-2018)

6.4 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Application (2013-2018)

6.4.1 Europe Benign Prostatic Hyperplasia Devices Sales and Sales Share by Application (2013-2018)

6.4.2 Europe Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific Benign Prostatic Hyperplasia Devices by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

7.1.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

7.1.3 China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

7.1.4 Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

7.1.5 Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

7.1.6 India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

7.1.7 Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

7.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Revenue (Value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

7.3.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Sales Share by Type (2013-2018)

7.3.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Type (2013-2018)

7.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Application (2013-2018)

7.4.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Sales Share by Application (2013-2018)

7.4.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Application (2013-2018)

8 South America Benign Prostatic Hyperplasia Devices by Countries, Type, Application and Manufacturers

8.1 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries

8.1.1 South America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

8.1.2 South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

8.1.3 Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

8.1.4 Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

8.1.5 Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

8.2 South America Benign Prostatic Hyperplasia Devices Sales and Revenue (Value) by Manufacturers (2016-2017)

8.2.1 South America Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2016-2017)

8.2.2 South America Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2016-2017)

8.3 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

8.3.1 South America Benign Prostatic Hyperplasia Devices Sales and Sales Share by Type (2013-2018)

8.3.2 South America Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Type (2013-2018)

8.4 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Application (2013-2018)

8.4.1 South America Benign Prostatic Hyperplasia Devices Sales and Sales Share by Application (2013-2018)

8.4.2 South America Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Application (2013-2018)

9 Middle East and Africa Benign Prostatic Hyperplasia Devices by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

9.1.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

9.1.3 Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

9.1.4 UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

9.1.5 Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

9.1.6 Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

9.1.7 South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

9.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Revenue (Value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

9.3.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Sales Share by Type (2013-2018)

9.3.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Type (2013-2018)

9.4 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Application (2013-2018)

9.4.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Sales Share by Application (2013-2018)

9.4.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Revenue Share by Application (2013-2018)

10 Global Benign Prostatic Hyperplasia Devices Market Segment by Type

10.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2013-2018)

10.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2013-2018)

10.2 Transurethral Resection of the Prostate (TURP) Sales Growth and Price

10.2.1 Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)

10.2.2 Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)

10.3 Transurethral Microwave Therapy (TUMT) Sales Growth and Price

10.3.1 Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)

10.3.2 Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)

10.4 Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth and Price

10.4.1 Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)

10.4.2 Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)

10.5 Laser Surgery Sales Growth and Price

10.5.1 Global Laser Surgery Sales Growth (2013-2018)

10.5.2 Global Laser Surgery Price (2013-2018)

10.6 Prostatic Stenting Sales Growth and Price

10.6.1 Global Prostatic Stenting Sales Growth (2013-2018)

10.6.2 Global Prostatic Stenting Price (2013-2018)

10.7 Others Sales Growth and Price

10.7.1 Global Others Sales Growth (2013-2018)

10.7.2 Global Others Price (2013-2018)

11 Global Benign Prostatic Hyperplasia Devices Market Segment by Application

11.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2013-2018)

11.2 Hospitals and Clinics Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)

11.4 Home Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)

12.2 Benign Prostatic Hyperplasia Devices Market Forecast by Regions (2018-2023)

12.2.1 North America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.2.2 Europe Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.2.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.2.4 South America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.2.5 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

12.3 Benign Prostatic Hyperplasia Devices Market Forecast by Type (2018-2023)

12.3.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)

12.3.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)

12.4 Benign Prostatic Hyperplasia Devices Market Forecast by Application (2018-2023)

12.4.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)

12.4.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Benign Prostatic Hyperplasia Devices Picture

Table Product Specifications of Benign Prostatic Hyperplasia Devices

Figure Global Benign Prostatic Hyperplasia Devices CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)

Figure Global Benign Prostatic Hyperplasia Devices CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)

Figure Global Sales Market Share of Benign Prostatic Hyperplasia Devices by Types in 2017

Figure Transurethral Resection of the Prostate (TURP) Picture

Table Major Manufacturers of Transurethral Resection of the Prostate (TURP)

Figure Transurethral Microwave Therapy (TUMT) Picture

Table Major Manufacturers of Transurethral Microwave Therapy (TUMT)

Figure Transurethral Needle Ablation of the Prostate (TUNA) Picture

Table Major Manufacturers of Transurethral Needle Ablation of the Prostate (TUNA)

Figure Laser Surgery Picture

Table Major Manufacturers of Laser Surgery

Figure Prostatic Stenting Picture

Table Major Manufacturers of Prostatic Stenting

Figure Others Picture

Table Major Manufacturers of Others

Figure Benign Prostatic Hyperplasia Devices Sales Market Share by Applications in 2017

Figure Hospitals and Clinics Picture

Figure Ambulatory Surgical Centers(ASC) Picture

Figure Home Picture

Figure Others Picture

Figure United States Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure France Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure UK Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure China Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure India Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)

Table Lumenis Headquarter, Established, Main Business and Finance Overview (2017)

Table Lumenis Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Lumenis Benign Prostatic Hyperplasia Devices Product

Table Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Lumenis Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Lumenis Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Olympus corporation Headquarter, Established, Main Business and Finance Overview (2017)

Table Olympus corporation Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Olympus corporation Benign Prostatic Hyperplasia Devices Product

Table Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Olympus corporation Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Olympus corporation Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Urologix Headquarter, Established, Main Business and Finance Overview (2017)

Table Urologix Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Urologix Benign Prostatic Hyperplasia Devices Product

Table Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Urologix Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Urologix Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Boston Scientific corporation Headquarter, Established, Main Business and Finance Overview (2017)

Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product

Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Boston Scientific corporation Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Lisa Laser Headquarter, Established, Main Business and Finance Overview (2017)

Table Lisa Laser Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Lisa Laser Benign Prostatic Hyperplasia Devices Product

Table Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Lisa Laser Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Lisa Laser Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Medifocus Headquarter, Established, Main Business and Finance Overview (2017)

Table Medifocus Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Medifocus Benign Prostatic Hyperplasia Devices Product

Table Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Medifocus Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Medifocus Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Neotrac Headquarter, Established, Main Business and Finance Overview (2017)

Table Neotrac Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Neotrac Benign Prostatic Hyperplasia Devices Product

Table Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Neotrac Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Neotrac Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table ProArc Medical LTD Headquarter, Established, Main Business and Finance Overview (2017)

Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product

Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global ProArc Medical LTD Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Urotech GMBH Headquarter, Established, Main Business and Finance Overview (2017)

Table Urotech GMBH Benign Prostatic Hyperplasia Devices Production Bases, Sales Regions and Major Competitors

Table Urotech GMBH Benign Prostatic Hyperplasia Devices Product

Table Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Market Share in 2017

Figure Global Urotech GMBH Benign Prostatic Hyperplasia Devices Revenue Market Share in 2017

Table Global Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table Global Benign Prostatic Hyperplasia Devices Price by Manufacturer (2016-2017)

Figure Top 3 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017

Figure Global Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales by Regions (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Regions (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Revenue by Regions (2013-2018)

Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2013

Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2017

Figure North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure North America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Figure Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Europe Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Figure South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure South America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Figure North America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)

Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2013

Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017

Table North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)

Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013

Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017

Figure United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table North America Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table North America Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Revenue by Application (2013-2018)

Table North America Benign Prostatic Hyperplasia Devices Revenue Share by Application (2013-2018)

Figure Europe Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2016

Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017

Figure Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table Europe Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table Europe Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Revenue by Application (2013-2018)

Table Europe Benign Prostatic Hyperplasia Devices Revenue Share by Application (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries 2017

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries 2017

Figure China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Application (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Share by Application (2013-2018)

Figure South America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)

Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017

Table South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)

Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017

Figure Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table South America Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table South America Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Revenue by Application (2013-2018)

Table South America Benign Prostatic Hyperplasia Devices Revenue Share by Application (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017

Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Figure South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016

Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Application (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Share by Application (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)

Figure Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)

Figure Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)

Figure Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)

Figure Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)

Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)

Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)

Figure Global Laser Surgery Sales Growth (2013-2018)

Figure Global Laser Surgery Price (2013-2018)

Figure Global Prostatic Stenting Sales Growth (2013-2018)

Figure Global Prostatic Stenting Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)

Table Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)

Figure Global Hospitals and Clinics Sales Growth (2013-2018)

Figure Global Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)

Figure Global Home Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Regions (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Regions (2018-2023)

Figure North America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

Figure Europe Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

Figure Asia-Pacific Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

Figure South America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

Figure Middle East and Africa Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)

Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Sample Request is not available

Shop Now

Buy Now

Quick Contact

+1